1. allergy or hypersensitivity to ivermectin and/or its inactive ingredients. 2. patients meeting covid-19 severity criteria, with respiratory distress or requiring intensive care. 3. using medications having potential activity against sars-cov-2 such as hydroxychloroquine, chloroquine, lopinavir, ritonavir, remdesivir, azithromycin in the last 3 months. 4. use of immunodepressants (including systemic corticosteroids) in the last 30 days. 5. known hiv infection with cd4 count \<300 cell/µl. 6. pregnant or lactating patients. 7. patients with other acute infectious diseases. 8. patients with medical conditions such as malabsorption syndromes affecting proper ivermectin absorption. 9. patients with acute allergy conditions or with severe allergic reactions background. 10. patients with autoimmune disease and/or decompensated chronic diseases. 11. patients with uncontrolled, intercurrent diseases including renal impairment, hepatic impairment, symptomatic congestive heart failure, unstable chest angina, heart arrhythmia or psychiatric conditions that may limit adherence to ct requirements.

1. allergy or hypersensitivity to ivermectin and/or its inactive ingredients. 2. patients meeting covid-19 severity criteria, with respiratory distress or requiring intensive care. 3. using medications having potential activity against sars-cov-2 such as hydroxychloroquine, chloroquine, lopinavir, ritonavir, remdesivir, azithromycin in the last 3 months. 4. use of immunodepressants (including systemic corticosteroids) in the last 30 days. 5. known hiv infection with cd4 count \<300 cell/µl. 6. pregnant or lactating patients. 7. patients with other acute infectious diseases. 8. patients with medical conditions such as malabsorption syndromes affecting proper ivermectin absorption. 9. patients with acute allergy conditions or with severe allergic reactions background. 10. patients with autoimmune disease and/or decompensated chronic diseases. 11. patients with uncontrolled, intercurrent diseases including renal impairment, hepatic impairment, symptomatic congestive heart failure, unstable chest angina, heart arrhythmia or psychiatric conditions that may limit adherence to ct requirements.

allergy or hypersensitivity to ivermectin and/or its inactive ingredients. patients meeting covid-19 severity criteria, with respiratory distress or requiring intensive care. using medications having potential activity against sars-cov-2 such as hydroxychloroquine, chloroquine, lopinavir, ritonavir, remdesivir, azithromycin in the last 3 months. use of immunodepressants (including systemic corticosteroids) in the last 30 days. known hiv infection with cd4 count <300 cell/µl. pregnant or lactating patients. patients with other acute infectious diseases. patients with medical conditions such as malabsorption syndromes affecting proper ivermectin absorption. patients with acute allergy conditions or with severe allergic reactions background. patients with autoimmune disease and/or decompensated chronic diseases. patients with uncontrolled, intercurrent diseases including renal impairment, hepatic impairment, symptomatic congestive heart failure, unstable chest angina, heart arrhythmia or psychiatric conditions that may limit adherence to ct requirements.

allergy or hypersensitivity to ivermectin and/or its inactive ingredients. patients meeting covid-19 severity criteria, with respiratory distress or requiring intensive care. using medications having potential activity against sars-cov-2 such as hydroxychloroquine, chloroquine, lopinavir, ritonavir, remdesivir, azithromycin in the last 3 months. use of immunodepressants (including systemic corticosteroids) in the last 30 days. known hiv infection with cd4 count <300 cell/µl. pregnant or lactating patients. patients with other acute infectious diseases. patients with medical conditions such as malabsorption syndromes affecting proper ivermectin absorption. patients with acute allergy conditions or with severe allergic reactions background. patients with autoimmune disease and/or decompensated chronic diseases. patients with uncontrolled, intercurrent diseases including renal impairment, hepatic impairment, symptomatic congestive heart failure, unstable chest angina, heart arrhythmia or psychiatric conditions that may limit adherence to ct requirements.

1. allergy or hypersensitivity to ivermectin and/or its inactive ingredients. 2. patients meeting covid-19 severity criteria, with respiratory distress or requiring intensive care. 3. using medications having potential activity against sars-cov-2 such as hydroxychloroquine, chloroquine, lopinavir, ritonavir, remdesivir, azithromycin in the last 3 months. 4. use of immunodepressants (including systemic corticosteroids) in the last 30 days. 5. known hiv infection with cd4 count <300 cell/µl. 6. pregnant or lactating patients. 7. patients with other acute infectious diseases. 8. patients with medical conditions such as malabsorption syndromes affecting proper ivermectin absorption. 9. patients with acute allergy conditions or with severe allergic reactions background. 10. patients with autoimmune disease and/or decompensated chronic diseases. 11. patients with uncontrolled, intercurrent diseases including renal impairment, hepatic impairment, symptomatic congestive heart failure, unstable chest angina, heart arrhythmia or psychiatric conditions that may limit adherence to ct requirements.

1. allergy or hypersensitivity to ivermectin and/or its inactive ingredients. 2. patients meeting covid-19 severity criteria, with respiratory distress or requiring intensive care. 3. using medications having potential activity against sars-cov-2 such as hydroxychloroquine, chloroquine, lopinavir, ritonavir, remdesivir, azithromycin in the last 3 months. 4. use of immunodepressants (including systemic corticosteroids) in the last 30 days. 5. known hiv infection with cd4 count <300 cell/µl. 6. pregnant or lactating patients. 7. patients with other acute infectious diseases. 8. patients with medical conditions such as malabsorption syndromes affecting proper ivermectin absorption. 9. patients with acute allergy conditions or with severe allergic reactions background. 10. patients with autoimmune disease and/or decompensated chronic diseases. 11. patients with uncontrolled, intercurrent diseases including renal impairment, hepatic impairment, symptomatic congestive heart failure, unstable chest angina, heart arrhythmia or psychiatric conditions that may limit adherence to ct requirements.